[Effectiveness of paromomycin-I against Leishmania garnhami in heterozygote albino mice].
D000818:Animals; D000965:Antimony / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D007896:Leishmaniasis / Q000188:drug therapy* / Q000276:immunology; D008536:Meglumine; D000077485:Meglumine Antimoniate; D051379:Mice; D009942:Organometallic Compounds; D010303:Paromomycin / Q000627:therapeutic use*
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D010303:Paromomycin; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony
Eficacia de la paromomicina-I contra Leishmania garnhami en ratones albinos heterocigotos.